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ABSTRACT
Combination of gypsum with carbonated hydroxyapatite (CHA) has shown to improve bone healing process. Soft
tissue biocompatibility test is required prior to clinical application of bone substitutes since the materials contact
with the soft tissues upon application and can cause severe inflammatory response. The aim of this study was to
evaluate histocompatibility of gypsum compared to combination of gypsum-CHA in subcutaneous tissue. Disks of
gypsum and gypsum-CHA were implanted on paravertebral subcutaneous tissue of 25 male Wistar rats. Histological
section were stained with Hematoxylin Eosin then evaluated and scored with a histological grading scale for soft-
tissue implants. A two-way ANOVA was used to analyze the histomorphometrical results with 95% confidence
interval (p<0.05). The results showed that acute inflammatory cells were found in both groups at 6 hour and on day
5 and 7 after implantation at similar level. Chronic inflammatory cells and capsule were observed on day 7, 14, and
21. Moreover, there was no significant difference (p>0.05) of histomorphometrics score between both implants in
each implantation periods. It could be concluded that histocompatibility level of gypsum and combination of gypsum-
CHA to soft tissue was the same until day 21 iof mplantation.
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ABSTRAK
Kombinasi gipsum dan karbonat hidroksiapatit (CHA) mampu meningkatkan proses penyembuhan tulang. Uji
biokompatibilitas jaringan lunak diperlukan sebelum bahan substitusi tulang digunakan di klinik oleh karena bahan
tersebut akan kontak dengan jaringan lunak dan dapat menimbulkan respon inflamasi yang lebih serius. Tujuan
penelitian ini adalah mengkaji histokompatibilitas gipsum dibandingkan dengan kombinasi gipsum-CHA di jaringan
subkutan. Cakram yang mengandung gipsum atau kombinasi gipsum-CHA diimplantasikan pada jaringan subkutan
paravertebral dari 25 tikus Wistar jantan. Potongan preparat histologi diwarnai dengan pewarna Hematoksilin Eosin
untuk selanjutnya dievaluasi dan diskor berdasarkan skala tingkat histologi untuk implan pada jaringan lunak. Data
histomorfometrik dianalisis dengan ANOVA dua jalan dengan tingkat kepercayaan 95% (p<0,05). Hasil penelitian
menunjukkan sel inflamasi akut ditemukan pada kedua kelompok pada jam ke 6, dan hari ke 5 dan 7 setelah implantasi
dengan derajad yang sama. Sel inflamasi kronis teramati pada hari ke 7, 14, dan 21. Tidak terdapat perbedaan skor
histomorfometrik secara bermakna antara gipsum dan kombinasi gipsum-CHA pada masing-masing periode implantasi.
Dapat disimpulkan bahwa gipsum dan kombinasi gypsum-CHA mempunyai tingkat histokompatibilitas yang sama
pada jaringan lunak sampai pada hari ke 21 setelah implantasi.
Kata kunci:  gipsum - karbonat hidroksiapatit – biocompatibilitas – histocompatibilitas - implantasi subkutan
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INTRODUCTION
Bone damage is one of health problems that
can cause chronic disability.1 Extensive bone damage
can not heal spontaneously hence bone substitute
materials are needed.2 Bone substitutes can be
obtained from patient’s own tissue (autograft), other
person (allograft), animals (xenograft), or from
synthetic materials. Autograft, allograft, and
xenograft  have several drawbacks such as donor
morbidity, tissue rejection and disease transmission.
 Recently, synthetic materials such as gypsum
and CHA have been developed to solve the problem.
Both materials have advantages and disadvantages.
Gypsum can fill irregular and small defect and evokes
minimal inflammatory response, nevertheless it is
resorbed in short time before sufficient new bone
growth occurs. Carbonated hydroxyapatite is a newly
developed synthetic material that has excellent
osteoconductivity and good resorbtion rate.3,4
Combining those two materials may produce better
materials for inducing bone regeneration.  Gypsum
can fill irregular defect and set in situ while the CHA
gives a slower biodegradation rate.
Biocompatibility test is required prior clinical
application of materials in order to evaluate body
rejection to the materials. Numerous studies showed
a favorable bone response to the materials,
nevertheless there is not much of publication
concerning soft tissue response to the materials.
Since bone substitutes contact not only with the
bone, but also with soft tissues, information about
biocompatibility of bone substitutes in soft tissue is
also essential. Soft tissue gives more severe
inflammatory response than bone.5  In this study,
soft tissue biocompatibility test was performed to
evaluate materials histocompatibility of combination
of gypsum with CHA in subcutaneous tissues of
the rats.
MATERIALS AND METHODS
This was an experimental study. The
experiments were conducted at Laboratory of
Histology and Cell Biology of Faculty of Medicine,
Laboratoly of Biomedic of Faculty of Dentistry, and
Integrated Research and Testing Laboratory, Gadjah
Mada University, Yogyakarta. The protocol of this
study has been approved by the Medical and Health
Research Ethics Committee, Faculty of Medicine,
Gadjah Mada University, Yogyakarta.
Twenty five male Wistar rats were divided into
5 groups with 5 rats on each group based on duration
of implantation i.e. day 0, 5, 7, 14 and 21.  Gypsum
implants preparation was prepared by mixing 2 mg
of calcium sulphate hemihydrates with 1 µL of
aquadest. Gypsum-CHA implant preparation was
prepared by mixing both materials with a ratio of
7:3. Two mg of gypsum-CHA mixture was then
added with 1 µL of aquadest. Both materials were
inserted into teflon cast to achieve a disc-shaped
mold with a diameter of 6 mm and 0.8 mm
thickness. These two types of implant materials were
then sterilized with a UV sterilizer before implanted
into subcutaneous tissue of the right and left
paravertebral areas. Five rats from each group were
sacrificed on day 0, 5, 7, 14, and 21 after
implantation. Implant and tissue around the implant
were dissected out and processed into paraffin
sections stained with hematoxylin eosin. Five serial
sections (FIGURE 1) from each block were
observed by two independent observers. Each slide
was evaluated in 4 fields in 700x magnification and
its histomorphometry was scored according to
previous criteria.12 The average scores were
analyzed by two way ANOVA with 95%  confidence
of interval.
FIGURE 1. Histological serial section of paraffin block
RESULTS
Visual evaluation
The conditions of all experimental animals in
this study were healthy with fluffy white fur. The
rats moved, ate and drank normally before and after
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FIGURE 2. The histological soft tissue post implantation of gypsum and combination gypsum-CHA
implantation. Postoperative wound on day 0 was
still wet and blood was visible. On day 5, the wound
started to dry and covered by crust. No blood or
exudate and only minimal edema can be observed.
On day 7, the wound was dry. Most crust were
already peeled and only left  a thin crust. On day
14, rat’s fur in the operation site began to grow and
the incision scar has closed. On day 21, the scar
was not visible since thick fur had grown covering
the area of the scar.
Microscopic evaluation
The histological feature of soft tissue post
implantation of gypsum and combination  gypsum-
CHA on day 0, 5, 7, 14 and 21 is presented on
FIGURE 2. The remaining materials were marked
by black star, while lines ended by arrows showed
the capsule thickness.
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On day 0, tissue reactions profile on both type
of implantation i.e. gypsum or combination gypsum-
CHA looked similar. The shape of implanted
materials was still intact. The implants were porous
without any newly developed connective tissue
around or within the implants. Erythrocytes and the
scattered acute inflammatory cells such as
polymorphonuclear leukocytes could be observed
in surrounding tissues and in the pores of both
implanted materials.
On day 5, the surface of both implants (gypsum
or combination gypsum-CHA) was started to degrade
and no erythrocytes can be observed in the surface.
Soft tissue began to contact with implant’s surface.
Compared to day 0, more polymorphonuclear
leukocytes were observed. However, there was no
surrounding capsule could be observed.
On day 7, the amount of the degraded parts of
the implant increased. Few tissues containing fibroblasts
and inflammatory cells has grown inside the implants.
Occasionally, foreign giant cells were seen. Only a few
scattered polymorphonuclear leukocytes were found.
A thin connective tissue capsule was formed. Capsule
surrounding gypsum was thicker than in gypsum-
CHA.Both implants were more degraded leaving more
pores filled by connective tissue.  Fibrous capsules
surrounding gypsum and gypsum CHA were thinner
than an day 7.
On day 14, Both implants were more degraded
leaving more pores filled by connective tissue. Blood
vessels and chronic inflammatory cells such as
lymphocytes and foreign giant cells scattered in the
connective tissue of the capsule and the implant’s
pores.  More foreign giant cells were found in
gypsum than in gypsum-CHA implanted tissue.
On day 21, Fibrous capsule surrounding
gypsum on day 21 was thinner than on day 14 and
also thinner compared to fibrous capsule surrounding
gypsum-CHA on day 21. The degradation process
continued and only some remaining materials can
be found in the tissue. The space left by the degraded
materials was filled by more abundant connective
tissue containing blood vessels and inflammatory
cells. More inflammatory cells were found in the
pores of implanted materials than in the capsule.
However, there were less inflammatory cells
observed compared to day 14’s tissue samples.
Histomorphometric evaluation
a. Capsule thickness
Histomorphometric evaluation was not
determined in tissue samples obtained  on day 0
and 5 since there was no clear capsule around the
implants could be observed. The mean score of
capsule thickness of gypsum-CHA group in each
period of implantation (FIGURE 3A) was always
higher than the gypsum except on day 21 but this
was not statistically significant (p>0.05). That higher
score indicated that better histocompatibility can be
observed on gypsum-CHA group.
The mean score of capsule thickness that
surrounds gypsum group increased along the
implantation period. On the other hand, the mean
score of capsule thickness in gypsum-CHA tissue
samples increased on day 14, but it decreased on
day 21. The significantly difference of mean scores
of capsule thickness between implantation periods
was observed in this study (p<0.05) especially
between day 7 with day 144and between day 7 with
day 21.
b. Capsule quality
For both materials, the pattern mean score of
capsule quality in each group was similar with the
capsule thickness mean score (FIGURE 3B).
Inflammatory cells infiltrate in capsule surrounding
gypsum group decreased from day 7 to day 21 with
score range 1.98-2.63, while in gypsum-CHA group
increased on day 21 with score range 2.15-2.29.
The increase was significantly different between day
7 with day 14 (p<0.05) and between day 7 with
day 21 (p<0.05), while mean score of capsule quality
between the two groups in each period was not
significantly different (p>0.05).
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FIGURE 3.  Histomorphometric bar carts. A. Capsule tickness; B. Capsule quality; C. Interface quality; D. Total score
c. Interface quality
Small numbers of foreign body giant cells were
found along the outer surface of both groups of
implants on day 7. The number increased on day
14 but then decreased on day 21. The mean scores
of interface quality in tissues implanted with gypsum
group always increased along with the implantation
periods, while in tissues implanted with gypsum-
CHA the scores decreased on day 21. However,
there was no statistical differences between the
scores in gypsum and gypsum-CHA groups (p>0.05)
and between implantation periods (p>0.05).
d. Total score
The pattern of total score of gypsum and
gypsum-CHA groups in each implantation period
and between implantation periods were similar with
capsule thickness and capsule quality (FIGURE
3D). The total score of gypsum-CHA group was
always higher than gypsum group except on day
21, but this was not significantly different (p>0.05).
The mean total score of gypsum group always
increased with the time periods but in gypsum-CHA
group, it decreased on day 21, however there was
no statistical difference (p>0.05).
DISCUSSION
The increase of quality of capsule surrounding
gypsum was marked by the reduction of
inflammatory cells infiltrates contained in the capsule,
within implantation period. While the quality of
capsule surrounding gypsum-CHA decreased on day
21. Gypsum is quickly resorbed in the body and it
trigger minimal inflammatory response. Both these
characteristics caused gypsum existence in soft tissue
only slightly stimulated inflammatory cells.10 On day
14, the remaining gypsum was less than on day 7,
and the remaining amount would be lesser on day-
21. Fragments released by the implanted material
could interfere wound healing process.15 Less
implant materials in the body would activate less
inflammatory cells. While inflammatory cells in
gypsum-CHA implantation on day 21 increased due
to CHA degradation on day 21. The degradation of
CHA was more slowly than the gypsum.13, 14 The
capsule quality surrounding gypsum-CHA was higher
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than in gypsum on day 7 and 21, since the amount
of gypsum in gypsum-CHA was less than in gypsum
implant.
The level of acute inflammation triggered by
gypsum and gypsum-CHA was similar. It was shown
by the amount of polymorphonuclear leukocytes
infiltrates that almost the same in both implants
materials. Acute inflammatory response could be
observed in the early implantation period (day 0, 5,
and 7) by the presence of monocytes and
polymorphonuclear leukocytes, whereas chronic
inflammatory response was observed in subsequent
periods (day 14 and 21) by the presence of
macrophages, foreign body giant cells, and
lymphocytes.  When implanted into soft tissues with
the same implantation procedure, gypsum and
combination of gypsum-CHA stimulated inflamma-
tory response, either acute or chronic. The presence
of an implant can provide a continuous inflammatory
stimulus.
The presence of polymorphonuclear leukocytes
which started from 6 hours (0 days) after treatment
showed that an acute response was already in
progress. Polymorphonuclear leukocytes, will work
early to eliminate cellular debris. Along with
increasing time, other inflammatory cells such as
monocytes, will flock the implantation area
simultaneously. The number of inflammatory cells
that come into the area of inflammation depends on
the injury circumstances and the implant materials
ability to stimulate inflammation. The type and
amount of inflammatory cells in the implantation
site will be different at each period of time.6 On day
14 and 21, inflammatory cells were dominated by
macrophages, foreign body giant cells, and
lymphocytes. Monocytes that come into the
inflammation area in acute period will turn into
macrophages. Macrophages will phagocyte debris
and foreign materials. Some macrophages will fuse
with foreign giant cell to increase its phagocytosis
ability. The presence of macrophages has impact
on implant material resorption rate.7,8
The interface quality, evaluated by the presence
of foreign body type giant cells on implanted gypsum
and gypsum-CHA decreased on day 14 and increased
again on day 21. On day 7, the number of monocytes
that came to the implant area and turned into
macrophages or foreign body type giant cells was
still a few on the acute phase. On day 14, more
monocytes would come and turned into
macrophages and foreign body giant cells. The
number of macrophage increased and some
macrophages fused to form a foreign giant cell in
attempt to clean the implant materials and cellular
debris.  On day 21, half of macrophages and foreign
body giant cells underwent apoptosis or followed
the lymphatic flow due to lack of remaining
gypsum.5 While in the gypsum-CHA implants, the
number of macrophages and foreign body giant cells
on day 21 was relatively constant. This was because
the particles resulted from CHA degradation on day
21 still triggered macrophages and foreign body cells
activation. Activated macrophages, foreign body
giant cells, monocytes, and other inflammatory cells
will produce growth factors and other inflammatory
mediators. These growth factors will activate
fibroblast to proliferate and produce extracellular
matrix surrounding implant materials.9
Capsule thickness surrounding gypsum
subsequently decreased on day 7, 14, and 21 since
less activated macrophages released growth factors
within implantation periods. On the other hand,
capsule thickness surrounding gypsum-CHA on day
21 was thicker than on day 14, since increase in
activated macrophages released more growth factor
due to stimulation by particles from CHA
degradation.  The mean score of capsule thickness
of gypsum and gypsum-CHA ranged from 1.10 to
2.35. These ranges of scores were almost the same
with score range of capsule thickness in cement
implantation á-tri calcium phosphate and precipitated
hydroxyapatite that reported to have a good
compatibility and caused minimal inflammatory
response with that score range.5
Gypsum and combination of gypsum-CHA
showed the ability to be adhered by surrounding
fibroblast cells since there was no gap between
material and surrounding connectives tissue. In
addition, both of these implant materials were able
to stimulate tissue growth into materials pores.
Those indicated that both gypsum and gypsum-CHA
were not toxic to the soft tissue.9
Total score criteria showed a similar pattern
with the thickness and quality of the capsule. Total
score of gypsum increased on day 14 and 21 because
of the nature of gypsum which triggers less
inflammatory response and to be on the wane after
the longer duration of implantation. The
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inflammatory response became less with the
decrease in content of gypsum in the soft tissue.
Total score of gypsum-CHA increased on day 14
and decreased on day 21 because CHA in this
combination began to degrade on day 21.
Degradation of the CHA stimulated the inflammatory
response in the surrounding soft tissue.
No statistical difference between gypsum and
combination of gypsum-CHA implants in capsule
quality, interface quality, capsule thickness, and total
score  indicated that gypsum and combination of
gypsum-CHA had the same histocompatibility level
in soft tissue until day 21 of implantation.
CONCLUSION
Gypsum and combinations of gypsum-CHA had
the same level of histocompatibility in soft tissue
until day 21 of implantation. Other compatibility
testing of the materials such as cytocompatibility,
infectability and hemocompatibility will be
conducted with longer implantation period, different
implantation procedure and a more suitable
histological technique. Measurement of residual
materials will also performed to evaluate the speed
of degradation of the implant materials.
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